Plain-English translation of NCT07539727 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is investigating whether intestinal ultrasound — a painless imaging test — can help doctors predict which Crohn's disease patients will experience a flare-up in the future. Researchers will follow 420 patients whose Crohn's disease is currently in deep remission (very well-controlled) for 18 months, comparing ultrasound images and other health data between those who stay stable and those who flare up. The goal is to develop a tool that might help doctors identify high-risk patients earlier and adjust treatment before symptoms return.
Right now, doctors rely on endoscopy (a camera procedure down the throat) to monitor Crohn's disease, but it's uncomfortable and requires bowel preparation, making it hard to do frequently. Ultrasound is non-invasive, requires no radiation, is cheaper, and patients tolerate it well — so this study aims to prove it can reliably predict who will relapse, making long-term monitoring easier and safer.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have intestinal ultrasound exams and standard endoscopy procedures at baseline, and the research team will track your health and symptoms over 18 months to see whether your disease stays in remission or flares up. You'll share your medical records, blood work results, and imaging scans with the study team. There are no new medications or procedures beyond what your regular doctor would do — this is purely observational research to understand whether ultrasound findings can predict future flare-ups.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China